0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      On Endocrine Orbitopathy

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          From previous clinical and experimental observations with animals it is clear that the exophthalmos producing factor (EPF) is not the only factor which is responsible for endocrine orbitopathy. Therefore, a study of the effect of ACTH, cortisol, adrenaline, testosterone, oestradiol and oestriol on experimental exophthalmos in fish was made. Preliminary investigations were also made with a view to finding the most suitable medium of administration of drugs to goldfish and the minimum quantity of EPF that can produce a definite exophthalmos. Two doses of 0.25 mg TSH in 0.7% sodium chloride solution were found to be most suitable for obtaining a minimum but definite exophthalmos. TSH in combination with ACTH and testosterone had a synergistic effect while oestradiol and cortisol were found to inhibit the action of EPF. Adrenaline produced exophthalmos which lasted for a short time; this effect is probably due to its vasoconstrictor action. Progesterone produced exophthalmos and in combination with EPF, their effects were additive. These results show that disturbances in the regulation of different hormones can produce endocrine orbitopathy.

          Related collections

          Author and article information

          Journal
          ORE
          Ophthalmic Res
          10.1159/issn.0030-3747
          Ophthalmic Research
          S. Karger AG
          0030-3747
          1423-0259
          1970
          1970
          27 November 2009
          : 1
          : 6
          : 344-353
          Affiliations
          Eye Clinic, University of Bonn, Bonn
          Article
          264534 Ophthal Res 1970;1:344–353
          10.1159/000264534
          © 1970 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 10
          Categories
          Paper

          Comments

          Comment on this article